|
TCEA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.307600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.087800E-01 |
| Normal-vs-Stage2 |
3.263200E-01 |
| Normal-vs-Stage3 |
1.963570E-02 |
| Normal-vs-Stage4 |
3.982100E-02 |
| Stage1-vs-Stage2 |
1.122560E-01 |
| Stage1-vs-Stage3 |
6.502500E-03 |
| Stage1-vs-Stage4 |
5.622900E-04 |
| Stage2-vs-Stage3 |
2.333400E-01 |
| Stage2-vs-Stage4 |
9.566200E-02 |
| Stage3-vs-Stage4 |
5.626000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.272200E-01 |
| Normal-vs-AfricanAmerican |
4.999200E-01 |
| Normal-vs-Asian |
4.307200E-01 |
| Caucasian-vs-AfricanAmerican |
5.394200E-01 |
| Caucasian-vs-Asian |
1.887400E-01 |
| AfricanAmerican-vs-Asian |
3.013400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.352000E-01 |
| Normal-vs-Female |
1.300280E-02 |
| Male-vs-Female |
1.719160E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.024400E-01 |
| Normal-vs-Extreme_Weight |
4.851600E-01 |
| Normal-vs-Obese |
1.449200E-01 |
| Normal-vs-Extreme_Obese |
9.129900E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.189200E-01 |
| Normal_Weight-vs-Obese |
6.119000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.488300E-02 |
| Extreme_Weight-vs-Obese |
6.890200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.922000E-01 |
| Obese-vs-Extreme_Obese |
3.118200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.403600E-02 |
| Normal-vs-Age(41-60Yrs) |
5.491400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.398000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.629200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.500200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.652300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.656200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.442200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.567800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.197000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.483210E-01 |
| Normal-VS-Type2 PRCC |
7.944400E-01 |
| Normal-VS-KIRP CIMP |
1.751560E-02 |
| Normal-VS-Unclassified PRCC |
8.474200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.131440E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.362270E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.405000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.873950E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.119000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.724430E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.110800E-01 |
| Normal-vs-N1 |
8.719600E-03 |
| Normal-vs-N2 |
3.316100E-02 |
| N0-vs-N1 |
4.439600E-03 |
| N0-vs-N2 |
9.545500E-02 |
| N1-vs-N2 |
1.120440E-01 |
|
|
